Viewing nowOstatin 20 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Os Korea Pharmaceutical Co., Ltd.

MFDS item code 201501555 · Approved 2015.03.24 · Insurance code 629700390
Improvement of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medication is used as an adjunct to diet for the treatment of primary hypercholesterolemia and mixed dyslipidemia in patients when dietary changes and exercise do not achieve adequate control. It also aids in patients with homozygous familial hypercholesterolemia along with diet or other lipid-lowering therapies and reduces total cholesterol and LDL cholesterol in patients with hypercholesterolemia, delaying the progression of atherosclerosis. It is also used as an adjunct to diet for children aged 10 to 17 years with heterozygous familial hypercholesterolemia and is beneficial in patients with dysbetalipoproteinemia. Furthermore, it is used in men over 50 years and women over 60 years with risk factors for cardiovascular disease to reduce the risk of stroke, myocardial infarction, and vascular revascularization procedures. It is effective for various types of dyslipidemia and reduction of cardiovascular disease risk.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; the dose may be adjusted to a maintenance dose if a greater reduction in LDL cholesterol is needed. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer, according to LDL cholesterol levels, treatment goals, and patient response; the dose may be increased up to a maximum of 20 milligrams per day. 3. Older adults: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary for patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dosage range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years: The safety and efficacy in children under 10 years of age have not been established.
This medication should not be used in certain patients. For example, patients with an allergy to this medication, severely impaired liver function, muscle disorders, severe renal impairment, or women who are pregnant or breastfeeding should not take this medication. This medication may affect liver function; therefore, patients with a history of liver disease or those who consume alcohol heavily should have regular liver function tests both prior to and during treatment. If symptoms such as muscle pain or weakness occur, it is important to inform a doctor immediately, and blood tests may be necessary to check for muscle damage. This medication can interact with other drugs; therefore, it is essential to inform your doctor or pharmacist of any other medications you are taking. Caution is especially needed when used in conjunction with specific antibiotics, antifungals, immunosuppressives, and fibrate drugs. Women of childbearing potential should use adequate contraception and should not take this medication during pregnancy. This medication is also not recommended while breastfeeding. In the case of overdose, since there is no specific antidote, it is crucial to go to the hospital immediately for appropriate treatment and to conduct liver function and muscle-related tests. This medication can rarely cause serious skin reactions, liver damage, or muscle damage; therefore, if skin rashes, jaundice symptoms, or severe muscle pain occur, use should be discontinued immediately and medical consultation sought. Caution is needed while driving or operating machinery as dizziness may occur.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, oculobulbar weakness, thrombocytopenia, jaundice, hepatitis, transaminase increase, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal hepatic failure, cognitive impairment, ALT increase, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature of 1 to 30 degrees Celsius. This will help to preserve the drug's effectiveness and safety.
Pink round film-coated tablet
30 tablets/box [(15 tablets/PTP (AluAlu) * 2)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Os Korea Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.